SCHEMBL753488

SCHEMBL753488

Cc1ccc(S(=O)(=O)O)cc1NCCS(=O)(=O)c1cc(C(=O)c2ccc(N)cc2)c(C)cc1C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NT5E P21589 1/20 0.33
▸ ENPP2 Q13822 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ CASP6 P55212 1/20 0.32
▸ CTDSP1 Q9GZU7 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ HDAC8 Q9BY41 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ MAPT P10636 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL753489 0.80 ALDH1A1 (0.35) ALDH1A1TSHRNT5EENPP2CA12
SCHEMBL753487 0.73 NSD2 (0.41) ALDH1A1TSHRNT5EENPP2CA12
SCHEMBL11526913 0.69 ALDH1A1 (0.46) ALDH1A1TSHRCYP1A2HPGDHSD17B10
SCHEMBL11758466 0.69 BRD4 (0.40) ALDH1A1TSHRMAPTPOLBHTT
SCHEMBL780499 0.66 ALDH1A1 (0.48) ALDH1A1CYP1A2HPGDHSD17B10KMT2A
SCHEMBL6660835 0.66 CYP3A4 (0.56) ALDH1A1TSHRCA12CA1CA2
SCHEMBL10485968 0.64 SNCA (0.44) ALDH1A1TSHRNT5ECA12CA1
SCHEMBL8958777 0.64 POLB (0.47) ALDH1A1TSHRNT5ECA12CA1
SCHEMBL10112765 0.64 MAPT (0.45) ALDH1A1CYP1A2HPGDHSD17B10MEN1
SCHEMBL11033531 0.64 PTGS2 (0.55) ALDH1A1TSHRCYP1A2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2669342-B1 ACTIVE-ENERGY-RAY-CURABLE INKJET INK COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INKJET INK, AND INKJET RECORDING METHOD KONICA MINOLTA INC (JP) 2020-03-18 — — EP disclosed
US-9416289-B2 Active-energy-ray-curable inkjet ink composition, active-energy-ray-curable inkjet ink, and inkjet recording method Konica Minolta, Inc. (JP) 2016-08-16 — — US disclosed
US-20130307913-A1 ACTIVE-ENERGY-RAY-CURABLE INKJET INK COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INKJET INK, AND INKJET RECORDING METHOD Konica Minolta, Inc. (JP) 2013-11-21 — — US disclosed
US-8349916-B2 Actinic energy radiation curable ink-jet ink, ink-jet recording method, and printed matter KONICA MINOLTA IJ TECHNOLOGIES, INC. (JP) 2013-01-08 — — US disclosed
EP-2228415-B1 Actinic energy radiation curable ink-jet ink, ink-jet recoring method, and printed matter KONICA MINOLTA IJ TECHNOLOGIES (JP) 2012-03-21 — — EP disclosed
US-20100255211-A1 ACTINIC ENERGY RADIATION CURABLE INK-JET INK AND INK-JET IMAGE FORMING METHOD KONICA MINOLTA IJ TECHNOLOGIES, INC. (JP) 2010-10-07 — — US disclosed
EP-2236568-A1 Actinic energy radiation curable ink-jet ink and ink-jet image forming method Konica Minolta IJ Technologies, Inc. (JP) 2010-10-06 — — EP disclosed
EP-2228415-A1 Acting energy radiation curable ink-jet ink, ink-jet recoring method, and printed matter Konica Minolta IJ Technologies, Inc. (JP) 2010-09-15 — — EP disclosed
US-20060287548-A1 Radical interceptors as stabilizers of polymerizable compounds BASF AKTIENGESELLSCHAFT (DE) 2006-12-21 — — US disclosed
US-20040082737-A1 Determination of the amount of polymer deposited from (meth) acrylic acid and/or (meth) acrylic esters BASF AKTIENGESELLSCHAFT (DE) 2004-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287548-A1 Radical interceptors as stabilizers of polymerizable compounds TTPA, AADAT, TSPO ALDH1A1 1648/4885TSHR 2691/4885NT5E 3208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback